Charles Schwab Investment Management Inc. Acquires 31,522 Shares of The Beauty Health Company (NASDAQ:SKIN)

Charles Schwab Investment Management Inc. lifted its stake in The Beauty Health Company (NASDAQ:SKIN) by 5.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 642,840 shares of the company’s stock after acquiring an additional 31,522 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.52% of Beauty Health worth $926,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of SKIN. Bank of New York Mellon Corp grew its position in Beauty Health by 24.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 348,108 shares of the company’s stock worth $668,000 after purchasing an additional 69,329 shares during the last quarter. Caprock Group LLC acquired a new stake in Beauty Health during the second quarter worth about $38,000. Federated Hermes Inc. grew its position in Beauty Health by 349,616.0% during the second quarter. Federated Hermes Inc. now owns 370,699 shares of the company’s stock worth $712,000 after buying an additional 370,593 shares in the last quarter. Susquehanna Fundamental Investments LLC bought a new position in Beauty Health during the second quarter valued at about $105,000. Finally, Sanctuary Advisors LLC acquired a new position in Beauty Health in the 2nd quarter valued at approximately $47,000. Institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Up 3.2 %

NASDAQ SKIN opened at $1.61 on Wednesday. The Beauty Health Company has a 1-year low of $0.91 and a 1-year high of $5.17. The company has a market capitalization of $199.83 million, a price-to-earnings ratio of -3.83 and a beta of 0.85. The stock’s 50 day moving average is $1.59 and its two-hundred day moving average is $1.66. The company has a current ratio of 6.56, a quick ratio of 5.57 and a debt-to-equity ratio of 9.23.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group lifted their price objective on Beauty Health from $1.25 to $1.75 and gave the stock a “hold” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $2.55.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.